Skip to content

To evaluate the safety and efficacy of laparoscopy-assisted laparoscopic general surgery in clinical trials

To evaluate the safety and efficacy of laparoscopy-assisted laparoscopic general surgery in clinical trials

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084622
Enrollment
Unknown
Registered
2024-05-21
Start date
2023-12-26
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General surgery

Interventions

Sponsors

Qinhuangdao First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Hepatobiliary pancreatectomy: Inclusion criteria: (1) 18-80 years old (inclusive), gender is not limited; (2) Patients who are determined by the researcher to need hepatobiliary pancreatectomy; (3) No other anti-tumor therapy or immunotherapy was performed before surgery; (4) no history of other malignant tumors; (5) Be able to cooperate with and complete follow-up and related examinations; (6) Voluntarily participate in the study and sign the informed consent. Radical gastrectomy: Inclusion criteria: (1) Pathological diagnosis of gastric cancer, stage I, II, III; (2) After comprehensive evaluation, it is suitable for radical gastrectomy; (3) Age 18-80 years old (inclusive), gender is not limited; (4) Be able to cooperate with and complete follow-up and related examinations; (5) Voluntarily participate in the study and sign the informed consent. Radical resection of colorectal cancer: Inclusion criteria: (1) Patients clinically diagnosed with colorectal tumors requiring colorectal resection; (2) There was no extensive invasion or distant metastasis in imaging examination; (3) Age 18-80 years old, gender unlimited; (4) Be able to cooperate with and complete follow-up and related examinations; (5) Voluntarily participate in this experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: Hepatobiliary pancreatectomy: Exclusion criteria: (1) Pregnant or lactating women; (2) Severe coagulation dysfunction, obvious bleeding tendency (platelets 30 kg/m2; (4) Patients with intestinal obstruction, bleeding or perforation requiring emergency surgery; (5) Pregnant or lactating women; (6) The ASA score is greater than grade II; (7) Participants in other investigational drug or device clinical trials have not been completed; (8) Patients considered unsuitable for this program by the investigator.

Design outcomes

Primary

MeasureTime frame
Non-conversion rate: no conversion from endoscopic system to other endoscopic methods Surgical system, laparoscopic surgery or open surgery.;

Secondary

MeasureTime frame
Operation time;Intraoperative blood loss, intraoperative blood transfusion, blood transfusion rate;Postoperative pain score;Incidence of device defect;Postoperative hospital stay;

Countries

China

Contacts

Public ContactWang Yimin

Qinhuangdao First Hospital

qhddrwym@163.com+86 186 0335 9028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026